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INTRODUCTION 
The anterior pituitary gland is known to play an 
important role in controlling many endocrine glands such 
as the adrenals, thyroid, mammary glands, and the gonads. 
The anterior pituitary gland secretes at least eight 
different hormones: luteinizing hormone (LH), follicle-
stimulating hormone (FSH) , growth hormone (GH) , thyroid 
stimulating hormone (TSH), prolactin (PRL), beta-endor-
phin, alpha-melanocyte stimulating hormone (alpha-MSH), 
and adrenocorticotrophic hormone (ACTH). LH and FSH 
regulate many parts of the reproductive system. For 
example, LH stimulates corpora lutea formation and 
ovulation in the female and testosterone secretion in the 
male. FSH is responsible for early development of the 
ovarian follicle in the female and initial spermatid 
maturation in the male. 
Although most of the pituitary hormones are local-
ized to one cell type in the pituitary, LH and FSH are 
localized in one of three cell types: cells that contain 
only LH, only FSH, or both LH and FSH. It is important to 
separate LH- and FSH-containing cells (gonadotropes) from 
a mixed population of anterior pituitary cells so that 
several questions can be addressed. For example, it has 
1 
been 
which 
2 
shown that gonadotropin-releasing hormone (GnRH), 
is secreted from the hypothalamus, will bind to 
receptors on the gonadotropes and cause the release of LH 
as well as FSH from the gonadotropes. It is not known, 
however, if GnRH causes the release of FSH from cells that 
contain only FSH or if GnRH causes FSH release only from 
cells that contain both LH and FSH. Once a pure cell 
population is achieved, it will be possible to treat cells 
that contain only FSH with GnRH in order to determine 
whether or not GnRH will cause the release of FSH from the 
cells or if another releasing factor is responsible for 
FSH release from these cells. This information would 
allow a better understanding of the feedback loops 
involved in reproduction and help to explain the nonpara-
llel release of LH and FSH in response to steroid hormones 
such as estradiol and progesterone during the menstrual or 
estrous cycle. 
A pure cell population of gonadotropes would also 
help address questions about the types of second messenger 
systems that control hormone release. It is important to 
understand which second messenger systems are involved in 
hormone release so that the mechanism of action of the 
hypothalamic hormones and the way a cell is differentially 
regulated can be better understood. It is not yet known 
if the same second messenger system is responsible for the 
release of LH or FSH from cells. These questions will 
3 
remain unanswered until the second messenger system of 
pure populations of cellscontaining only LH, only FSH, or 
both hormones can be studied with out interference from 
other cell types. 
There is also evidence that cells that contain FSH 
may also contain ACTH. With a pure population of cells 
containing only FSH, it would be possible to measure the 
cells for ACTH content. 
Once a valid separation procedure is established, as 
this thesis project proposes, it will become possible to 
address some of the aforementioned questions as well as 
others. Once some of these questions are answered, a 
better understanding of the reproductive system will be 
achieved. 
SPECIFIC AIMS 
1. To develop a rapid, inexpensive, and reliable method 
to separate cells that contain and secrete I.JI from a mixed 
population of rat anterior pituitary cells. 
2. To use this new method to support the hypothesis that 
I.JI and FSH are secreted from pituitary cells that contain 
only I.JI, only FSH, or both I.JI and FSH. 
4 
LITERATURE REVIEW 
The anterior pituitary gland is known to secrete at 
least eight different hormones: luteinizing hormone (LH), 
follicle-stimulating hormone (FSH) , growth hormone (GH), 
thyroid stimulating hormone (TSH), prolactin (PRL), beta-
endorphin, alpha-melanocyte stimulating hormone (alpha-
MSH), and adrenocorticotrophic hormone (ACTH). It is 
important to study the secretion of these various hormones 
to understand the function and dysfunction of almost all 
parts of the endocrine system, since the pituitary 
hormones regulate endocrine organs in many parts of the 
body. LH and FSH in particular are responsible for 
control of reproductive function via the gonads, and thus 
are referred to as gonadotropins. LH is known to stimu-
late corpora lutea formation and ovulation in the female 
and to stimulate testosterone secretion in the male. This 
testosterone secretion causes the development of male 
secondary sexual characteristics such as hair growth and 
distribution, enlargement of the sex organs, and develop-
ment of horns and antlers in some species.1 FSH is known 
to stimulate follicular growth in the ovaries and is 
necessary to increase spermatogenic activity in the 
testes.1,2 As early as 1954, electron microscopic studies 
5 
6 
showed that the anterior pituitary cell population 
contains at least two different types of gonadotropes 
(gonadotropin-secreting cells) . Farquhar and Rinehart 
were able to show with electron microscopy that one type 
contained rounded, light vesicular nuclei and ovoid 
cytoplasmic vesicles, whereas a second type contained 
dense, elongated or folded nuclei and irregularly shaped 
vesicles separated by cytoplasmic strands.3 Through this 
work, Purves and Griesbach determined that one type of 
cell was primarily 
pituitary gland and 
located centrally.3 
located near the periphery of the 
that the other type of cell was 
In order to determine which cell type 
secreted LH and which cell type secreted FSH, Purves and 
Griesbach treated adult female rats with testosterone and 
then observed the pituitary cells from these rats via 
electron microscopy. The electron micrographs showed that 
the peripheral cells had increased in size and that the 
central cells had been reduced in size. Purves and 
Griesbach concluded that the peripheral cells were FSH 
gonadotropes since testosterone had been previously shown 
to cause an increase in FSH secretion. They also con-
eluded that the central cells were LH gonadotropes since 
testosterone had been previously shown to cause a decrease 
in LH secretion.3,4,5 
Although these early studies do suggest that LH 
gonadotropes are centrally located and that FSH gonado-
7 
tropes are peripherally located, due to the lack of 
immunocytochemical techniques, scientists were unable to 
show definitely that the hormone contained in or secreted 
from the centrally or peripherally located cells was Lll or 
FSH. In addition, the aforementioned technique was unable 
to detect pituitary cells that contained both Lll and FSH. 
Several immunocytochemical studies have shown that 
some pituitary gonadotropes exhibit morphologies in which 
a single cell can contain both FSH and Lll.5,6,7 One of the 
earliest immunocytochemical studies performed by Nakane 
involved the use of double-staining anterior pituitary 
cell populations for both Lll and FSH. From this study, 
Nakane concluded that a high percentage of gonadotropes 
present in the anterior pituitary contained both FSH and 
Lll. 6 The results of these immunocytochemical studies 
caused scientists to dispute the "one-cell-one-hormone" 
hypothesis, which states that each individual cell 
produces and secretes only one hormone. 
These studies raised several important questions 
regarding the way that Lll and FSH from the same cell are 
differentially regulated in response to only one releasing 
hormone (gonadotropin-releasing hormone) . For example, it 
is possible that in addition to gonadotropin releasing 
hormone (GnRH), other releasing hormones exist which may 
serve to cause the release of hormone from only FSH-
containing cells, Lll-containing cells, or cells that 
8 
contain both LH and FSH. 
To study the biochemical mechanisms controlling 
secretion in specific cell types, a pure cell population 
is ultimately required. Thus, it is necessary to develope 
an effective method of separating mixed populations of 
anterior pituitary cells. A technique known as velocity 
sedimentation at unit gravity has been used to obtain 
enriched pituitary gonadotrope populations. This techni-
que employs the theory that the majority of the hormone 
contained within a pituitary cell is stored in secretory 
granules of varying size and density. Thus, cells that 
are more dense due to containment of larger and more dense 
secretory granules will sediment at a higher density in a 
gradient made of 0.3-2.4% bovine serum albumin (BSA) 
maintained at unit gravity than cells that are less dense. 
The more dense cells can then easily be separated from 
cells containing smaller and less dense secretory gran-
ules. 8,9,10,ll Although this procedure can provide a 6 
to 8-fold enrichment of gonadotropes, several other 
limiting factors exist. Gradient instability can occur 
because of convection currents generated by improper 
lighting or by room vibrations, and cell-cell interactions 
have to be avoided by using only a small number of 
cells.8,9 It is also critical to use only a small number 
of cells during this procedure since when too many cells 
are layered over a BSA gradient, ideal sedimentation no 
9 
longer occurs. Once ideal sedimentation no longer occurs, 
predictable cell separation is no longer possible. 9 In 
addition, it has been shown that this method does not 
allow separation of adult rat pituitary cells into pure 
gonadotrope populations due to their tendency to spread 
along a gradient.12 
In an attempt to eliminate some of the problems en-
countered with velocity sedimentation at unit gravity, a 
process known as centrifugal elutriation was developed. 
During this procedure, dispersed pituitary cells are 
centrifuged in an elutriator chamber, causing the cells to 
settle toward the bottom of the chamber due to centrifugal 
force, while buffer is pumped upward through the chamber, 
causing the cells also to move upward. Thus, the cells 
are forced to form a layered gradient. The cells in the 
chamber are then collected in fractions by increasing the 
flow rate of buff er through the bottom of the elutriator 
chamber. This procedure will allow 300 million cells to 
be collected and separated on the basis of size with a 78% 
or better recovery and thus provide an adequate number of 
enriched cells to be obtained for further studies.12 
Centrifugal elutriation is also rapid compared to velocity 
sedimentation at unit gravity, requiring only 80 minutes 
to separate and collect cells, compared with 4 hours or 
more by velocity sedimentation at unit gravity.8,11 This 
procedure, however, still lacks the resolution necessary 
for studies of biochemical mechanisms for 
secretion since it does not produce pure 
lations. 8 
10 
gonadotropin 
cell popu-
The third technique developed for separating mixed 
cell populations is known as fluorescence-activated cell-
sorting. In this procedure, fluorescent dyes are coval-
ently bound to antibodies that are directed against a 
cell-surface antigen such as a receptor or other protein. 
A fluorescence-activated cell-sorter is then used to 
separate fluorescently labeled cells from unlabeled 
cells.13,14,15,16 Thorner et al. have shown with this 
method that pituitary cells that are bound to anti-LH 
fluorescent microspheres can be separated from a mixed 
pituitary population to obtain an enriched fraction of 
gonadotropes.13 This population was enriched from a 
normal control range of 7.4 ± 1.4% to 52.3 ± 11% of sorted 
cells.13 This procedure tends to be relatively ineffi-
cient because only 29.5 ± 3.2% of the total rat anterior 
pituitary cell population can be recovered from the cell 
sorter.13 This procedure is also quite expensive since it 
requires the availability of a fluorescence-activated 
cell-sorter. 
Another technique that has proven useful in studying 
secretion from specific cell types is the reverse hemo-
lytic plaque assay. 1 7' 18' 19 This technique employs the 
assumption that a particular hormone will be radially 
11 
dipensed around the cell that secreted it and that this 
region can be visualized. 
persed pituitary cells 
During this procedure, monodis-
and a suspension of protein-A 
coated ovine erythrocytes are incubated in a chamber 
constructed of a poly-L-lysine-coated glass microscope 
slide. This incubation allows the pituitary cells to 
attach to the chamber. After attachment, the incubation 
chamber is then filled with an appropriate hormone-
specific antiserum. Once the antiserum has attached to 
the specific hormone, the protein-A coated erythrocytes 
that were in suspension with the monodispersed pituitary 
cells tend to attach to the complex since protein-A binds 
to gammaglobulins present in the antiserum. 
then added to the chamber, which causes 
Complement is 
lysis of the 
hormone bound protein-A coated ovine erythrocytes. This 
lysis then causes the formation of areas of hemolysis 
(reverse plaques}. Plaques are then visualized and 
measured with a calibrated ocular micrometer. In add-
ition, the calibrated ocular micrometer can be used to 
quantitate the amount of a particular hormone present. To 
date, this technique has been used to observe secretion of 
I.JI, GH, and Prl, but only one abstract has been published 
on use of this technique to observe FSH secretion.17,18,19 
Although this method is a simple, rapid, and sensitive 
method for detecting hormone secretion by a single cell, 
it may not prove useful for the study of FSH since it is 
12 
difficult to obtain anti-FSH antibodies suitable for use 
with immunological techniques.20 
Another technique that has been used to sort living 
pituitary cells is known as forward angle and perpen-
dicular light scatter.2l,2 2 During this procedure, 
pituitary cells are separated using a cell sorter in which 
an argon laser is used to generate a light scatter 
perpendicular to a pituitary cell population. In addi-
tion, a forward angle light scatter is also generated from 
a pituitary cell population. It is generally agreed that 
the forward angle light scatter will diffract light 
dependant on the size of the cell. It is also generally 
agreed that perpendicular light scatter will cause a 
reflection and refraction of light that is dependant on 
internal structures of the cell such as the ratio of 
nuclear-cell diameter, cytoplasmic secretory granule 
content, nuclear shape, and distribution of cytoplasmic 
organelles. Therefore, if one assumes that the size and 
internal structure of the cells to be separated differ 
from the rest of the cell population, separation can be 
achieved. There are basically two major drawbacks to this 
type of a separation procedure: 1) the assumption that 
size and internal structure differs among pituitary cells 
and 2) the cost of a cell-sorter. 
Recently, separation techniques have been developed 
that use magnetic principles to separate cells into pure 
13 
fractions. Early magnetic separation techniques could 
only be performed on red blood cells, which are intrin-
sically magnetic, or on phagocytic cells, which could 
ingest magnetic beads. Magnetic particles now can be 
attached via antibodies to cell surfaces to render them 
magnetic, since all cell types have specific markers or 
proteins on their surfaces.23,24,25,26 Cells attached to 
magnetic particles can then be separated from cells not 
attached to magnetic particles by simply applying a 
magnetic field. This procedure has been used successfully 
to separate CD8+T cells from peripheral blood suspensions 
and tumor cells from bone marrow.18,20,27,28 To date, the 
use of magnetic separation techniques to separate mixed 
populations of anterior pituitary cells has been un-
reported. When this procedure is applied to rat anterior 
pituitary cells, as this thesis project proposes, magnetic 
beads coated with an anti-Lll or anti-FSH antibody will be 
used to separate Lll-secreting or FSH-secreting cells from 
the rest of the cell population. Therefore, once the 
separation of gonadotropes from a mixed population of rat 
anterior pituitary cells has been achieved, the hypothesis 
for this thesis project will be that lJI and FSH are 
secreted from pituitary cells thatcontain only Lll, only 
FSH, or both lJI and FSH. 
MATERIALS AND METHODS 
Activation of magnetic beads 
In all experimental procedures, the magnetic beads 
used were made of polystyrene with a magnetite core and a 
diameter of 4.5 um (DynabeadsR). I activated the magnetic 
beads according to a procedure outlined by the manufac-
turer (Dynal Inc.) to prepare the surface of the beads for 
conjugation to an antibody. I first subjected the 
magnetic beads to a series of washes with acetone, in 
order to remove water from the magnetic beads. In order 
to transfer the magnetic beads to acetone, I first 
suspended the beads in a 7:3 water:acetone mixture (1.5 ml 
mixture/4.8 x 108 magnetic beads). I then collected the 
magnetic beads by centrifugation for 10 min at 23,000 g or 
with a magnetic particle collector for 5 min. After 
collection of the magnetic beads, I resuspended the 
magnetic beads in a 6:4 water:acetone mixture for 5 
minutes. I then collected the magnetic beads as above and 
resuspended them in a 2: 8 water: acetone mixture for 5 
minutes. After collection of the magnetic beads again, I 
resuspended the magnetic beads in 1. 5 ml acetone for 5 
minutes. After this resuspension, I recollected the 
magnetic beads. I perf armed the resuspension in 1. 5 ml 
14 
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fresh acetone 3 times. Once the washes were completed, I 
resuspended the magnetic beads in 1.5 ml acetone and added 
o.75 mmol pyridine and 1.5 mmol p-toluenesulphonyl chlor-
ide/30 mg undiluted magnetic beads. I then incubated the 
mixture for 20 h with end-over-end rotation at room 
temperature. After incubation, I collected the magnetic 
beads by centrifugation or with a magnetic particle 
collector as described above and washed the magnetic beads 
3 times in 1.5 ml acetone. After each wash, I collected 
the magnetic beads as previously mentioned. I then trans-
ferred the beads back to water through a series of washes 
in which I sequentially resuspended the magnetic beads in 
1.5 ml of 2:8, 6:4, and 7:3 water:acetone mixtures. I 
once again collected the magnetic beads by the af oremen-
tioned methods. Finally, I stored the now-activated 
magnetic beads in 1 mM HCl until needed for further use. 
The manufacturer of these magnetic beads has determined 
that activated magnetic beads can be stored for 12 months 
in 1 mM HCl at 4°c. 
Conjugation of magnetic beads 
I conjugated the activated magnetic beads to a 
suitable antibody according to a procedure recommended by 
the manufacturer. The anti-LH antibody that I used was 
anti-bLH-518-b?, a monoclonal anti-LH antibody kindly 
provided by Dr. Jan Roser of the University of California 
16 
at Davis. In addition, I also conjugated normal mouse 
serum (NMS) to magnetic beads as a negative control. NMS 
was used as a negative control since anti-bLH-518-b7 was 
raised in a mouse and since NMS does not bind specifically 
to LH or FSH. According to the recommended procedure, I 
first washed the activated magnetic beads 3 times in 1 ml 
sterile distilled water. I then resuspended the magnetic 
beads in 1 ml sterile distilled water. I diluted NMS or 
anti-LH antibody in 0.2 M borate buffer, pH 9.5, to obtain 
a final concentration of 150 ug protein/ml. I added 
diluted NMS or anti-LH antibody to the washed magnetic 
beads to achieve an antibody:magnetic bead ratio of 75 
ug:15 mg and incubated this mixture for 24 h by slow end-
over-end rotation at room temperature. Once the incuba-
tion period was over, I collected the magnetic beads with 
a magnetic particle collector for 5 min or by centri-
fugation at 23, 000 g for 10 min. I then washed the 
magnetic beads with 1.5 ml 0.1 M phosphate-buffered saline 
(PBS) pH 7.4 for 10 min.; 1.5 ml 1 M ethanolamine-HCl, pH 
9.5, with 0.1% (vol/vol) Tween 20 for 2 h; 1.5 ml 0.05 M 
Tris-Cl with 0.1 M NaCl, 0.1% (wt/vol) bovine serum 
albumin (BSA), 0.01% merthiolate, and 0.1% Tween 20, pH 
7.5, for 12 h; and 1.5 ml 0.05 M Tris-Cl with 0.1 M NaCl, 
0.1% BSA, and 0.01% merthiolate, pH 7.5, for 2 h. I then 
collected the NMS-coated or antibody-coated magnetic beads 
by centrifugation or with a magnetic particle collector 
17 
and stored them in O. 05 M Tris-Cl, pH 7. 4, with O .1 M 
NaCl, O .1% BSA, and O. 01% merthiolate until needed for 
further use. 
Specificity check for the binding of anti-LH antibody to 
the magnetic beads 
I ran two standard tests to ensure that anti-LH 
antibody was bound to the magnetic beads and that the 
binding of the antibody-coated beads to antigen was 
specific. I ran test one to show specificity through a 
dose-response curve and test two to show specificity 
through a dose-inhibition curve. A dose-response curve 
exhibits specificity by showing that binding of radiolab-
eled hormone to a specific antibody increases as the 
concentration of the antibody increases. A dose inhibi-
tion curve exhibits specificity by showing that radiolab-
eled hormone and nonradiolabeled hormone will compete for 
binding to antibody against the hormone. I ran these 
tests according to procedures A and B below: 
A. Specificity check 1 
During this procedure I incubated O. 05, O .1, O. 2, 
O. 4, o. 8, 1. 6, and 3. 2 ul magnetic beads conjugated to 
anti-bLH-518-b7 (518b7db) with 125r-LH (50,000 cpm/50 ul) 
and PBS, pH 7.0, with 0.1% (wt/vol) gelatin (PBS-gel) in a 
total volume of 150 ul. 
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In addition, I also incubated 
magnetic beads conjugated to NMS (NMSdb) with PBS-gel and 
125r-LH as a control to determine the amount of non-
specific binding of radioactive hormone to the magnetic 
beads. I performed the incubation for 2 4 h at room 
temperature in 1% gelatin-coated disposable glass culture 
tubes. The gelatin helped to prevent proteins from 
binding to the glass. After the incubation period, I 
added 2 ml cold PBS to each tube and centrifuged the tubes 
at 1700 g for 2 h. I then decanted the supernatants and 
washed the tubes with an additional 2 ml cold PBS. I then 
used an automatic gamma counter to determine the amount of 
bound radiolabeled hormone on the dynabeads in the tube. 
I replicated this experiment three times. 
B. Specificity check 2 
During this procedure, I incubated a constant 
concentration of 518b7db (O.l ul) and 50 ul 125r-LH 
(50,000cpm/50 ul) with various concentrations of non-
radiolabeled LH (0.02, 0.06, 0.2, 0.63, 2.01, 6.34, 20.03, 
63.3, and 200.0 ng/200 ul) and PBS-gel or non-radiolabeled 
FSH (0.30, 0.59, 1.19, 2.38, 4.75, 9.5, 19.0, and 38.0 
ng/200 ul) and PBS-gel in a total incubation volume of 475 
ul. In addition, I incubated tubes containing NMSdb (0.1 
ul) with 50 ul radiolabeled hormone and the various 
concentrations of non-radiolabeled hormone as described 
19 
above. The incubation took place in 1% gelatin-coated 
glass culture tubes at room temperature for a period of 24 
h. After the incubation period, I washed the tubes and 
determined the amount of bound radiolabeled hormone as 
described in specificity check 1. 
experiment three times. 
I replicated this 
Time Course Binding Study 
I ran a time course binding check to determine the 
amount of time that antibody remains conjugated to the 
magnetic beads. During this procedure, I incubated o .1 
and 0.2 ul 518b7db or NMSdb with 125r-LH (50,000 cpm/50 
ul) and PBS-gel in a total volume of 150 ul. In addition, 
I incubated 200 ul 1:400 normal rabbit serum (NRS) in 
ethylene diamine tetraacetic acid-PBS (EDTA-PBS) or 
1:45,000 anti-rLH-S9 in NRS with 500 ul PBS-gel and 125r-
LH (100,000 cpm/100 ul). These tubes served as a control 
to determine the amount of binding lost over time due to 
decay of the radioactive hormone. 
of specific binding of 125r-LH 
Therefore, if the ratio 
to 518b7db specific 
binding of 125r-LH to anti-rLH-S9 remained constant over 
time, I would show that binding was not lost over time due 
to the antibody dissociating from the magnetic beads. I 
incubated the tubes for 24 h at room temperature. After 
the incubation period, I added 50 ul protein-A (1 mg IgG 
binding capacity/ml) to the control tubes, incubated at 
20 
4oc for 15 min, and then washed and centrifuged all the 
tubes as previously described. I then determined the 
amount of bound radiolabeled hormone as described in 
specificity check 1. 
week for 5 weeks. 
Radioimmunoassay (RIA) 
I perf armed this procedure once a 
I used assays for LH, FSH, TSH, and Prl according to 
standard laboratory procedures with reagents obtained from 
the National Pituitary Agency.29,30,31,32,33,34 I 
radioiodinated all hormones by the chloramine T method. 
The intra-assay coeffients of variation (CVs), inter-
assay CVs, and upper and lower limits of detectability are 
described in Table 1. 
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Table 1 : RIA CV's and limits of detectability 
I determined intra-assay and inter-assay coeff-
icients of variation for LH, FSH, TSH, and Prl radio-
immunoassays (RIA) that I used in Experiments 1 and 2. I 
also determined the upper and lower levels of detect-
ability for the aforementioned assays. 
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Table 1 
Intra-assay Inter-assay 
Hormone Lower level Upper level 
ng/tube ng/tube 
LH 5.9% 6.5% 0.125 4.0 
FSH 4.2% 7.2% 1.19 4.75 
TSH 10.1% 19.1% 0.122 3.4 
Prl 10.1% 11.2% 0.176 9.24 
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Experiment 1 
Once the aforementioned procedures were followed, I 
used antibody-coupled beads in the following methods to 
separate freshly dissociated rat anterior pituitary cells. 
I replicated Experiment 1 and Experiment 2 three times. 
A. Animals 
I used female rats at least six weeks of age that 
were bred in Loyola University of Chicago's animal care 
facility for all the following experimental procedures. 
This animal care facility is APHIS-accredited and staffed 
by a full-time animal care technician. The temperature in 
the facility was maintained at 22-2s0 c and the light cycle 
was maintained with 12 h dark: 12 h light. 
were allowed food and water ad libitum. 
The animals 
B. Cell culture 
I enzymatically dissociated 30 rat pituitaries 
according to standard laboratory techniques. 35, 36 Once 
the cells were dissociated, I added culture medium 
[Dulbeccos Modified Eagles Medium {DMEM) , 10% 
fetal bovine serum, 100,000 U/ml mycostatin, 
{vol/vol) 
and 1% 
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(vol/vol) penicillin-streptomycin] to a final volume of 15 
ml. I then removed 2.6 x 106 cells from the final dis-
sociated population, which I plated at 200,000 cells/well 
(1.5 ml/well) in 16 mm culture dishes. These cells served 
as control cells. I then had approximately 52. 4 x 106 
cells left. I placed 1 x 10 7 cells into each of three 
separate sterile siliconized culture tubes with rubber 
stoppers. To transfer the cells to the tubes I gently 
pipetted the correct volume of cells into three separate 
tubes. One of these tubes received 518b7db and was 
separated as described below. one tube did not receive 
518b7db and served as a control for the incubation periods 
and treatments described below (incubated-only cells). 
The third tube received 518b7db, but was not separated as 
described below (nonseparated cells). This tube served as 
a control for the presence of magnetic beads during the 
incubation periods and treatments described below. 
c. Addition of magnetic beads and GnRH 
I pipetted 1.0 x 108 518b7db (0.250 ml) into the 
tube that contained the cells to be used for the separa-
tion procedure and into the tube that contained cells that 
were to serve as nonseparated control. This number of 
magnetic beads was ten times the number of cells, so that 
a negative selection could be achieved. This excess 
should remove most of the cells secreting LH from the 
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mixed cell population, but may also remove some non-LH-
secreting cells. I then added GnRH to the tubes in a 
final concentration of io-9 M to cause maximal secretion 
of gonadotropins from the cells. Once the cells, anti-
body-coated beads, and GnRH were added to the tubes, I in-
cubated the tubes with an end-over-end rotator at room 
temperature for 4 h. During this incubation, I aerated 
the cells with a 95% o2/5% co2 mixture for 30 s every 
hour. 
D. Separation of bound cells from unbound cells 
After incubation for 4 h, I placed one of the tubes 
containing 518b7db and GnRH in a magnetic particle 
concentrator for 5 min to separate bound cells from 
unbound cells. I then removed the unbound population with 
a pasteur pipet and placed the cells into a sterile 
siliconized tube. I then resuspended the bound population 
in 3 ml culture medium. Thus I was left with 4 tubes 
containing: bound cells, unbound cells, incubated-only 
cells, and nonseparated cells. Since the bound cells from 
each tube would be approximately 10% of the population4, 
Table 2 gives a good approximation of the number of cells 
I expected to have in each tube: 
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Table 2 : Separation procedure using 518b7db 
I separated LH-secreting cells from a mixed anterior 
pituitary population with the use of 518b7db. I divided a 
mixed population of cells into 3 separate tubes. I added 
gonadotropin releasing hormone (GnRH) to each of the tubes 
and added 518b7db to 2 of the tubes. I then put tube 1 
into a magnetic particle concentrator to separate the 
cells bound to 518b7db from cells that were not bound to 
518b7db. 
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Table 2: Separation procedure using 518b7db 
55 x 106 cells after dissociation 
Divide cells into three separate tubes 
tube 1 tube 2 tube 3 
10 x 106 cells 10 x 106 cells 10 x 106 cells 
+ + + 
GnRH GnRH GnRH 
I 
+ + I 
I 
518b7db 518b7db I 
I I 
I I 
Separate bound cells I I 
from unbound cells I I 
I I I 
I I I 
tube 1 tube 4 tube 2 tube 3 
1 x 106 9 x 106 10 x 106 10 x 106 
cells cells cells cells 
(bound) (unbound) (nonsep) (inc-only) 
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E. Treatment of cells with HEPES buffer 
After the above procedure was followed, I treated 
half of each population with HEPES buffer (25 mM HEPES, 1 
mg/ml BSA, 1% penicillin-streptomycin, pH 7.4) with or 
without trypsin (1 mg/ml). I performed the trypsin 
treatment in order to dissociate the magnetic beads from 
the bound cells after separation was completed. In order 
to add the HEPES buffer with or without trypsin, I 
centrifuged the tubes in a clinical IEC centrifuge at 
setting 6 for 5 min. I then aspirated the supernatant 
with a pasteur pipet. Once the supernatant was aspirated, 
I then added HEPES buffer with or without trypsin ( 1 ml 
solution/2 x 106 cells) . I then incubated each tube of 
cells for 40 min at 37°c. After the incubation period, I 
placed the bound populations of cells that were treated 
with HEPES buffer with or without trypsin in a magnetic 
particle concentrator. This procedure separated the bound 
cells from the magnetic beads. I then transferred the 
cells to another tube with a pasteur pipet. After this 
separation, I stopped the trypsin reaction in every tube 
by adding 8 ml culture medium. I then washed the cells 
three times with culture medium. To wash the cells, I 
centrifuged the cells in a clinical IEC centrifuge at 
setting 6 for 5 min, aspirated the supernatant with a 
pasteur pipet, added 5 ml culture medium, and gently 
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resuspended the cells with a pasteur pipet. 
F. Plating of cells 
I plated the cells from the aforementioned tubes at 
200,000 cells/well (1.5 ml/well). 
G. Incubation of cells 
I then incubated the cells for 48 h at 370c in a 
water-saturated atmosphere of 95% air-5% co2 . After 48 h, 
I removed the medium and washed the cells once with fresh 
DMEM to remove any free antibody or magnetic beads. I 
then replenished the wells with fresh culture medium. I 
incubated the plates again for 24 h. 
H. Assays 
After incubation for 24 h, I collected the cells and 
the media and assayed for LH and FSH by RIA. To collect 
the media, I removed the media from the plates with a 
pasteur pipet. To collect the cells, I first added lysis 
buffer to the plates (0.05 M Na2co3 , 2 mM EDTA, 45,000 U/g 
bacitracin, pH 8.5).37 I then froze and thawed the cells 
two times. This procedure caused the cells to break apart 
and release their contents into the buffer. I stored the 
samples at -20°c until RIA. 
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Experiment 2 
After I determined that the magnetic beads used in 
the aforementioned experiment could be removed by treating 
the cells with HEPES buffer without trypsin, I performed 
the following separation experiment so that I could assay 
the bound and unbound fractions of cells for LH, FSH, TSH, 
and PRL. It was necessary to assay both the bound and 
unbound fractions to show that the separation procedure 
works. In addition, I used NMSdb as a control for 
nonspecific binding in the separation procedure. It was 
necessary to use NMSdb as a control because Experiment 1 
did not allow me to show that the separation procedure 
specifically removed LH-secreting cells due to specific 
binding of 518b7db to LH-secreting cells. 
A. Cell culture 
I enzymatically dissociated 30 rat pituitaries 
according to standard laboratory techniques. 3 5' 3 6 Once 
the cells were dissociated, I removed 2 x 106 cells, which 
I plated at 200, 000 cells/well. These cells served as 
control cells. I had approximately 53.5 x 106 cells left, 
which I placed into two separate sterile siliconized 
culture tubes with rubber stoppers. 
B. Addition of magnetic beads and GnRH 
I added 1.925 x 108 518b7db (0.481 ml) to one tube 
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and 1. 925 x 108 NMSdb ( o. 481 ml) to the other tube. I 
added GnRH to both tubes to a final concentration of 10-9 
M. I then incubated and aerated the tubes as previously 
described. 
c. Separation of bound cells from unbound cells 
After the incubation period, I placed each of the 
two tubes in a magnetic particle concentrator for 5 min. 
I removed the unbound populations with a pasteur pipet and 
placed them into two separate sterile siliconized tubes. 
I resuspended the bound populations in 3 ml culture 
medium. Thus, I was left with four tubes containing: 
518b7db-bound cells, 518b7db-treated cells that remained 
unbound, NMSdb-bound cells, and NMSdb-treated cells that 
remained unbound. 
D. Treatment with HEPES buffer 
After the above procedure was followed, I treated 
all four tubes with HEPES buffer for 40 min as previously 
described. After the incubation period, I removed the 
magnetic beads as previously described. I also washed and 
plated the cells as previously described. 
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E. Incubation of cells 
I then incubated the cells for 48 h at 370c in a 
water-saturated atmosphere of 95% air-5%co2 . After 48 h, 
I washed the cells twice with DMEM. I then treated some 
cells from each magnetic bead treatment group with 
different releasing factors. In order to add the differ-
ent releasing factors to the cells, I replenished the 
cells with fresh culture medium containing the following 
releasing factors: gonadotropin-releasing hormone cio-9 
M), corticotropin-releasing hormone (10-8 M), growth 
hormone-releasing hormone (lo-8 M), or thyrotropin-
releasing hormone (10-7 M). I also replenished some cells 
from each group with fresh challenge medium without 
releasing factors as a control. The concentrations of 
releasing hormones that I used were consistent with 
physiological concentrations found in the litera-
ture38, 39, 40. I then incubated the cells for 24 h. 
F. Assays 
After incubation for 24 h, I collected the cells and 
media as previously described. I then assayed the samples 
for LH, FSH, TSH, and Prl by RIA. 
Statistics 
A. Specificity checks 
I calculated the mean + SEM for three experiments in 
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specificity checks 1 and 2. 
B. Experiment 1 
I analyzed the effect of treatment with HEPES buffer 
with or without trypsin on the concentration of LH and FSH 
in media, on LH and FSH cell content, and on total LH and 
FSH by analysis of variance with trypsin treatment, 
replicate, and dynabead treatment as the main effects. I 
used Tukey's test to determine differences between 
control, bound, unbound, incubated-only, and nonseparated 
cells. 
c. Experiment 2 
I analyzed the effect of treatment with magnetic 
beads and releasing factors on the concentration of LH, 
FSH, PRL, and TSH in media and within the cells by 
analysis of variance with releasing factor treatment, 
replicate, and magnetic bead treatment as the main 
effects. When a significant F-value was encountered, I 
used Tukey's test to determine significant differences 
between treatment means. 
Results 
A. Specificity check 1 for 518b7db 
Fig. 1 shows that flpecific binding of 125r-LH to 
518b7db increased as the concentration of 518b7db in-
creased. This specific binding increased to 34% of total 
radioactivity. Fig. 1 also shows that specific binding of 
125I-FSH to 518b7db did not increase as the concentration 
of 518b7db increased. The specific binding of 125r-FSH to 
each concentration of 518b7db remained near 0%. 
B. Specificity check 2 for 518b7 
Fig. 2 shows that when 518b7db were incubated with 
a constant amount of 125r-LH and increasing amounts of 
nonradiolabeled LH, higher amounts of nonradiolabeled LH 
decreased specific binding from 42% to 5% of total 
radioactivity. Fig. 2 also shows that when 518b7db were 
incubated with a constant amount of 125r-LH and increasing 
amounts of nonradiolabeled FSH, specific binding of 125r-
LH to 518b7db remained above 40% of total radioactivity 
regardless of the concentration of nonradiolabeled FSH 
used. 
c. Time course binding check 
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Fig. 3 shows that the ratio of specific binding of 
125r-LH to 518b7db : specific binding of 125r-LH to anti-
rLH-S9 during week 1 was 2. 74. During the time course 
experiment, the ratio did not change. 
D. Experiment 1 
1. LH medium 
Fig. 4 shows the amounts of LH/200,000 cells 
secreted into the medium by the control, bound, unbound, 
incubated-only (inc-only), and nonseparated (nonsep) 
cells. The bound secreted 1. 5-fold more LH than con-
trols, 5-fold more than the unbound population, and 2-fold 
more than the inc-only or nonsep cell populations (p<.05). 
There were no significant differences between the amounts 
of LH secreted by control, inc-only, and nonsep cells. 
The unbound population secreted 60% less LH than the 
control group (p<. 05). There was no significant dif-
ference between the unbound, the inc-only, and the nonsep 
cells. 
2. Cellular LH 
Fig. 5 shows the amounts of LH/200,000 cells 
contained in the control, bound, unbound, inc-only, and 
non-sep cells. The bound population of cells contained 
1.7-fold more LH than control, 7-fold more than the 
unbound population, 2.5-fold more than the inc-only cells, 
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and 2-fold more than the nonsep cell populations (p<.05). 
There were no significant differences between the amounts 
of LH contained in the control, inc-only cells, and nonsep 
treatment groups. The unbound population contained 76% 
less LH than the control group (p<. 05). There were no 
significant differences between the amounts of LH con-
tained in the unbound, the inc-only, and the nonsep cells. 
3. Total LH 
Fig. 6 shows total LH/200,000 cells in the control, 
bound, unbound, inc-only, and nonsep treatment groups. 
The bound population of cells contained 1.7-fold more 
total LH than control, 6-fold more than the unbound 
population, 2. 3-fold more than the inc-only cells, and 
2.1-fold more than the nonsep cell population (p<.05). 
There were no significant differences between the amounts 
of total LH in the control, inc-only, and nonsep cells. 
The unbound population contained 73% less total LH than 
the control group (p<. 05). There were no significant 
differences between the amounts of total LH in the 
unbound, inc-only, and nonsep treatment groups. 
4. Medium FSH 
Fig. 7 shows the amounts of FSH/200,000 cells 
secreted into the medium by the control, bound, unbound, 
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inc-only, and nonsep treatment groups. The bound pop-
ulation of cells secreted 2.5-fold more FSH than control, 
11.2-fold more than the unbound population, and 3.8-fold 
more than the inc-only and the nonsep cell populations 
(p<. 05) . There were no significant differences between 
the amounts of FSH secreted by the control, unbound, inc-
only, and nonsep cells. 
5. Cellular FSH 
Fig. 8 shows the amounts of FSH/200, 000 cells 
contained in the control, bound, unbound, inc-only, and 
nonsep treatment groups. There were no significant 
differences between the amounts of FSH contained in any of 
these treatment groups. 
6. Total FSH 
Fig. 9 shows the total amounts of FSH/200,000 cells 
contained in the control, bound, unbound, inc-only, and 
nonsep treatment groups. There were no significant dif-
ferences between the total amounts of FSH contained in 
cells from any of these treatment groups. 
E. Experiment 2 
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1. Effects of releasing factors 
The effects of GnRH, TRH, CRH, and GHRH on the 
different magnetic bead treatment groups were inconsistent 
and no statistical analyses could be performed. 
2. Medium LH 
Fig. 10 shows the amounts of LH/200,000 cells 
secreted into the medium by control, 518b7db-bound cells 
(b518b7), 518b7db-treated cells that remained unbound 
(u518b7), NMSdb-bound cells (bNMS), and NMSdb-treated 
cells that remained unbound (uNMS). B518b7 cells secreted 
1.7-fold more LH than control, 2-fold more than bNMS, 3.8-
fold more than uNMS cells, and 15-fold more LH than u518b7 
cells (p<.05). There was no significant difference 
between the amounts of LH secreted by control, uNMS, and 
bNMS cells. There also was no significant difference 
between the amounts of LH secreted by control, u518b7, and 
uNMS cells. There was, however, a significant difference 
between the bNMS and u518b7 cells. BNMS cells secreted 
7.5-fold more LH than u518b7 cells (p<.05). 
3. Cellular LH 
Fig. 11 shows the amounts of LH/200,000 cells con-
tained in control, b518b7, u518b7, bNMS, and uNMS cells. 
B518b7 cells contained 2.5-fold more LH than control, 3.8-
fold more than uNMS, and 14.8-fold more than u518b7 cells 
(p<. 05) . 
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There were no significant differences between 
the amounts of LH contained in control, uNMS, and u518b7 
cells. There were also no significant differences between 
the amounts of LH contained in b518b7 and bNMS cells. 
BNMS cells contained 10. 4-fold more LH than u518b7 and 
2. 7-fold more than uNMS cells {p<. 05), but there was no 
significant difference between bNMS and control cells. 
4. Total LH 
Fig. 12 shows the amounts of total LH/200,000 cells 
in control, b518b7, u518b7, bNMS, and uNMS cells. B518b7 
cells contained 2.6-fold more total LH than control, 1.65-
fold more than bNMS, 3.8-fold more than uNMS, and 14.8-
fold more than u518b7 cells {p<. 05). There were no 
significant differences between the amounts of total LH in 
uNMS and control cells. BNMS cells contained 2. 3-fold 
more total LH than uNMS, 9-fold more than u518b7, and 1.6-
fold more than control cells {p<.05). U518b7 cells 
contained 7 4. 2% less total LH than uNMS cells and 82. 7% 
less than control cells (p<.05). 
5. Medium FSH 
Fig. 13 shows the amounts of FSH/200,000 cells 
secreted into the medium by control, b518b7, u518b7, bNMS, 
and uNMS cells. B518b7 cells secreted 8.6-fold more FSH 
than u518b7, 2.2-fold more than bNMS, 4.2-fold more than 
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uNMS, and 2.6-fold more than control cells (p<.05). Cells 
separated using NMSdb (uNMS and bNMS) secreted the same 
amount of FSH as control cells. FSH secreted by u518b7 
cells was not significantly different from control, but 
was only 12 % of the amount of FSH secreted by bNMS cells 
(p<. 05). 
6. Cellular FSH 
Fig. 14 shows the amounts of FSH/200,000 cells 
contained in control, b518b7, u518b7, bNMS, and uNMS 
cells. B518b7 cells contained 3. 8-fold more FSH than 
u518b7, 2-fold more than bNMS, 2. 8-fold more than uNMS, 
and 3-fold more than control cells (p<.05). There were no 
significant differences between the amounts of FSH con-
tained in u518b7, bNMS, uNMS, and control cells. 
7. Total FSH 
Fig. 15 shows the total amounts of FSH/200,000 cells 
contained in control, b518b7, u518b7, bNMS, and uNMS 
cells. B518b7 cells contained 5. 4-fold more total FSH 
than u518b7, 2.2-fold more than bNMS, 3.5-fold more than 
uNMS, and 2.7-fold more than control cells (p<.05). 
Control cells contained 9 ng FSH/200,000 cells, with bNMS 
containing 20% more and uNMS containing 30% less (p<.05). 
UNMS cells, however, contained 50% less total FSH than 
control cells and 1.5-fold more than u518b7 cells (p<~05). 
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s. Medium PRL, cellular PRL, and total PRL 
Figs. 16 and 17 show the amounts of PRL/200, ooo 
cells secreted by and contained in control, b518b7, 
u518b7, bNMS, and uNMS cells. Fig. 18 shows the total 
amount of PRL/200, 000 cells contained 
bead treatment group. There were no 
in each magnetic 
significant dif-
f erences between the amounts of PRL in any treatment 
group. 
9. Medium TSH, cellular TSH, and total TSH 
Figs. 19 and 20 show the amounts of TSH/200, 000 
cells secreted by and contained in control, b518b7, 
u518b7, bNMS, and uNMS cells. Fig. 20 shows the total 
amount of TSH/2 00, ooo cells contained 
bead treatment group. There were no 
in each magnetic 
significant dif-
f erences between the amounts of TSH in any treatment 
groups, except control cells contained 1.2-fold more total 
TSH than uNMS cells (p<.05). 
42 
Figure 1 : Specificity check 1 
During Specificity check 1, I incubated 0.05., 0.1, 
0.2, 0.4, o.a, 1.6, and 3.2 ul 518b7db with 125r-LH or 
125I-FSH, and PBS-gel for 24 h at room temperature. 
Specific binding of 125r-LH to 518b7db increased as the 
concentration of 518b7db increased, while the specific 
binding of 125r-FSH to 518b7 remained near 0%. All points 
represent the mean ± SEM of three experiments. 
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Figure 2 : Specificity check 2 
During Specificity check 2, I incubated 0.1 ul 
518b7db with 50 ul 125r-LH and various concentrations of 
nonradiolabeled LH or FSH for 24 h at room temperature. 
Nonradiolabeled LH inhibited 125r-LH from binding to 
518b7db whereas nonradiolabeled FSH did not. Points 
represent the mean ± SEM of three experiments. In some 
cases, the error bars are smaller than the symbols. 
C) 
z 
0 
z 
co 
u 
LL 
u 
w 
D.... 
U1 
~ 
45 
Figure 2 
50 I 
T + + + 
0-·-·~.-. -·-·- --· / 40 1 l ,.--~ -""-i 
.\ l 30 
20 ... • 
~ ·-· 10 ... LH FSH ·-------•-o 
O+-~~-+-~~~~-+-~~~__,f--~~~-+----' 
0.02 0.1 0 1.00 10.00 100.00 
[LH] or [FSH] (ng/200ul) 
46 
Figure 3 : Time-course binding study 
During the time-course binding study, I incubated 
0.01 ul 518b7db or NMSdb with 50 ul 125r-LH for 24 h. In 
addition, I also incubated 200 ul NRS or 200 ul anti-rLH-
S9 with 100 ul 125r-LH as a control for radioactive decay. 
I calculated the ratio of specific binding of 1251-LH to 
518b7db:specific binding of 1251-LH to anti-rLH-S9 to 
determine if binding of 1251-LH to 518b7db was decreased 
over time. During the five week period that the binding 
checks were performed, there was no loss in binding of 
125!-LH to 518b7db. 
47 
Figure 3 
4 
VI 
"-.._ [/) 
Ll I 
I 
_J 
3 Ll L 
co 
... I I 
,,- ~ 
l[) c 
01 0 
c 
v 2 ... 
c 
..0 
u 
;,.:: 0 
u ~ 
OJ 0 
0... (l) 
(/) Q. 
~ 
(.!) 
~ 
I I 
i I I 0 
0 2 3 4 5 6 
Weeks 
48 
Figure 4 : Experiment 1-Medium LH 
I measured LH via RIA in medium samples of bound, 
unbound, incubated-only (inc-only), and nonseparated 
(nonsep) cells. Treatment groups that were treated with 
HEPES buffer with or without trypsin were not signif-
icantly different from each other and so were combined for 
presentation here. Bars represent the mean ± SEM of three 
experiments with the SEM having been determined from the 
error mean square of the analysis of variance. Bars with 
different letters are significantly different from each 
other as determined by Tukey's test. 
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Figure 5 : Experiment 1-Cellular LH 
I measured LH via RIA in cell lysates of the bound, 
unbound, incubated-only (inc-only), and nonseparated 
(nonsep) cells. Treatment groups that were treated with 
HEPES buffer with or without trypsin were not signif-
icantly different from each other and so were combined for 
presentation here. Bars represent the mean ± SEM of three 
experiments, with the SEM having been determined from the 
error mean square of the analysis of variance. Bars with 
different letters are significantly different from each 
other as determined by Tukey's test. 
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Figure 6 : Experiment 1-Total LH 
I calculated total LH by adding medium and cellular 
LH values obtained in the bound, unbound, incubated-only 
(inc-only), and nonseparated (nonsep) cells. Treatment 
groups that were treated with HEPES buffer with or without 
trypsin were not statistically different from each other 
and so were combined for presentation here. Bars rep-
resent the mean ± SEM of three experiments, with the SEM 
having been determined from the error mean square of the 
analysis of variance. Bars with different letters are 
significantly different from each other as determined by 
Tukey's test. 
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Figure 7 : Experiment 1-Medium FSH 
I measured FSH via RIA in medium samples of the 
bound, unbound, incubated-only (inc-only), and non-
separated (nonsep) cells. Treatment groups that were 
treated with HEPES buffer with or without trypsin were not 
significantly different from each other and so were 
combined for presentation here. Bars represent the mean ± 
SEM of three experiments, with the SEM having been 
determined from the error mean square of the analysis of 
variance. Bars with different letters are significantly 
different from each other as determined by Tukey's test. 
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Figure 8 : Experiment 1-Cellular FSH 
I measured FSH via RIA in cell lysates of the bound, 
unbound, incubated-only (inc-only), and nonseparated 
(nonsep) cells. Treatment groups that were treated with 
HEPES buffer with or without trypsin were not signifi-
cantly different from each other and so were combined for 
presentation here. Bars represent the mean ± SEM of three 
experiments, with the SEM having been determined from the 
error mean square of the analysis of variance. Bars with 
different letters are significantly different from each 
other as determined by Tukey's test. 
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Figure 9 : Experiment 1-Total FSH 
I calculated total FSH by adding medium and cellular 
FSH in the bound, unbound, incubated-only (inc-only), and 
nonseparated (nonsep) cells. Treatment groups that were 
treated with HEPES buffer with or without trypsin were not 
significantly different from each other and so were 
combined for presentation here. Bars represent the mean ± 
SEM of three experiments, with the SEM having been 
determined from the error mean square of the analysis of 
variance. Bars with different letters are significantly 
different from each other as determined by Tukey's test. 
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Figure 10 : Experiment 2-medium LH 
I measured LH via RIA in media of cells bound to 
518b7db (b518b7), not bound to 518b7db (u518b7), bound to 
NMSdb (bNMS), not bound to NMSdb (uNMS), and control 
cells. I treated some cells from each group with GnRH, 
TRH, CRH, GHRH, or no releasing factor. Bars represent 
the mean ± SEM of three experiments, with the SEM having 
been determined from the error mean square of the analysis 
of variance. Groups with different letters are sig-
nificantly different from each other as determined by 
Tukey's test. 
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Figure 11 : Experiment 2-cellular LH 
I measured LH via RIA in lysates of cells bound to 
518b7db (b518b7), not bound to 518b7db (u518b7), bound to 
NMSdb (bNMS), not bound to NMSdb (uNMS), and control 
eel 1 s . I treated some eel 1 s from each group with GnRH, 
TRH, CRH, GHRH, or no releasing factor. Bars represent 
the mean ± SEM of three experiments, with the SEM having 
been determined from the error mean square of the analysis 
of variance. Bars with different letters are signif-
icantly different from each other as determined by Tukey's 
test. 
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Figure 12 : Experiment 2-total LH 
I calculated total LH by adding the medium and 
cellular values for the cells bound to 518b7db (b518b7), 
not bound to 518b7db (u518b7), bound to NMSdb (bNMS), not 
bound to NMSdb (uNMS), and control cells. Bars represent 
the mean ± SEM of three experiments, with the SEM having 
been determined from the error mean square of the analysis 
of variance. Bars with different letters are signifi-
cantly different from each other as determined by Tukey's 
test. 
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Figure 13 : Experiment 2-medium FSH 
I measured FSH via RIA in media of cells bound to 
518b7db (b518b7), not bound to 518b7db (u518b7), bound to 
NMSdb (bNMS), not bound to NMSdb (uNMS), and control 
cells. I treated some cells from each group with GnRH, 
TRH, CRH, GHRH, or no releasing factor. Bars represent 
the mean ± SEM of three experiments, with the SEM having 
been determined from the error mean square of the analysis 
of variance. Bars with different letters are signifi-
cantly different from each other as determined by Tukey's 
test. 
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Figure 14 : Experiment 2-cellular FSH 
I measured FSH via RIA in lysates of cells bound to 
518b7db (b518b7), not bound to 518b7db (u518b7), bound to 
NMSdb (bNMS), not bound to NMSdb {uNMS), and control 
cells. I treated some cells from each group with GnRH, 
TRH, CRH, GHRH, or no releasing factor. Bars represent 
the mean ± SEM of three experiments, with the SEM having 
been determined from the error mean square of the analysis 
of variance. Bars with different letters are signifi-
cantly different from each other as determined by Tukey's 
test. 
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Figure 15 : Experiment 2-total FSH 
I calculated total FSH by adding the medium and 
cellular values for the cells bound to 51Bb7db (b51Bb7), 
not bound to 518b7db (u518b7), bound to NMSdb (bNMS), not 
bound to NMSdb (uNMS), and control cells. Bars represent 
the mean ± SEM of three experiments, with the SEM having 
been determined from the error mean square of the analysis 
of variance. Bars with different letters are signifi-
cantly different from each other as determined by Tukey's 
test. 
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Figure 16 : Experiment 2-medium PRL 
I measured PRL via RIA in media of cells bound to 
518b7db (b518b7), not bound to 518b7db (u518b7), bound to 
NMSdb (bNMS), not bound to NMSdb (uNMS), and control 
cells. I treated some cells from each group with GnRH, 
TRH, CRH, GHRH, or no releasing factor. Bars represent 
the mean ± SEM of three experiments, with the SEM having 
been determined from the error mean square of the analysis 
of variance. 
~ 
3500 
en 
3000 
2500 
2000 
c 
"'--" 1500 
1000 
:::E 
::J 
500 
0 
Figure 16 
DO 
-GnRH 
~TRH 
~ 
l2Z2J CRH 
~ ~GHRH 
~ 
~ ~ 
~ ~ 
~ 
~ 
~ 
~ 
~ ~ 
~ b ~ 
I/ b v 
~ i, b 
p ~ v ~ i, 
~ [, ~ I/ b / ~ ~ 
~ b D ~ v ~ v 
~ [, ~ [, b / ~ v 
~ ~ b ~ 
~ ~ v / ~ ~ 
b518b 7 u518b 7 bNMS uNMS control 
MAGNETIC BEAD TREATMENT GROUP 
73 
74 
Figure 17 : Experiment 2-cellular PRL 
I measured PRL via RIA in lysates of cells bound to 
518b7db (b518b7), not bound to 518b7db (u518b7), bound to 
NMSdb (bNMS), not bound to NMSdb (uNMS), and control 
cells. I treated some cells from each group with GnRH, 
TRH, CRH, GHRH, or no releasing factor. Bars represent 
the mean ± SEM of three experiments, with the SEM having 
been determined from the error mean square of the analysis 
of variance. 
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Figure 18 : Experiment 2-total PRL 
I calculated total PRL by adding the medium and 
cellular values for the cells bound to 518b7db (b518b7), 
not bound to 518b7db (u518b7), bound to NMSdb (bNMS), not 
bound to NMSdb (uNMS), and control cells. Bars represent 
the mean ± SEM of three experiments, with the SEM having 
been determined from the error mean square of the analysis 
of variance. 
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Figure 19 : Experiment 2-medium TSH 
I measured TSH via RIA in media of cells bound to 
518b7db (b518b7), not bound to 518b7db (u518b7), bound to 
NMSdb (bNMS) , not bound to NMSdb (uNMS) , and control 
cells. I treated some cells from each group with GnRH, 
TRH, CRH, GHRH, or no releasing factor. Bars represent 
the mean ± SEM of three experiments, with the SEM having 
been determined from the error mean square of the analysis 
of variance. 
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Figure 20 : Experiment 2-cellular TSH 
I measured TSH via RIA in lysates of cells bound to 
518b7db (b518b7), not bound to 518b7db (u518b7), bound to 
NMSdb (bNMS), not bound to NMSdb (uNMS), and control 
cells. I treated some cells from each group with GnRH, 
TRH, CRH, GHRH, or no releasing factor. Bars represent 
the mean ± SEM of three experiments, with the SEM having 
been determined from the error mean square of the analysis 
of variance. 
25 
(j) 
() 
0 20 0 ,.. 
0 
0 
0 
N 15 "-.... 
en 
c 
"'-' 
,......., 
10 
5 
0 
Figure 20 
c:JO 
•GnRH 
l:SSSl TRH 
EZZl CRH 
~GHRH 
l 
I I 
l l 
~ ~ 
] l , ~ I I ~ v ~ ~ v 
~ v x ~ / ~ LI ~ v ~ 
~ v x / ~ ~ ~ v ~ x ~ / x ~ ~ v 
~ v x / ~ x ~ v ~ v / v ~ ~ v ~ v ~ 
b518b7u518b7 bNMS uNMS control 
MAGNETIC BEAD TREATMENT GROUP 
81 
82 
Figure 21 : Experiment 2-total TSH 
I calculated total TSH by adding the medium and 
cellular values for the cells bound to 518b7db (b518b7), 
not bound to 518b7db (u518b7), bound to NMSdb (bNMS), not 
bound to NMSdb (uNMS), and control cells. Bars represent 
the mean ± SEM of three experiments, with the SEM having 
been determined from the error mean square of the analysis 
of variance. Bars with different letters are signifi-
cantly different from each other as determined by Tukey's 
test. 
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Discussion 
The purpose of this thesis project was to develop a 
new method to separate LH-cells from a mixed population of 
rat anterior pituitary cells with the use of anti-LH 
antibody-coated magnetic beads (518b7db) . Once this 
method was developed, it was used to support the hy-
pothesis that LH and FSH are both contained in and 
secreted from the same pituitary cell. Before I performed 
the separation experiments, I first performed specificity 
checks 1 and 2 so that I could be certain that 518b7db 
were specific for LH. Through specificity check 1, I 
showed that 518b7db were specific for LH because binding 
of 125r-LH to 518b7db increased as the concentration of 
518b7db increased, whereas there was no specific binding 
of 125I-FSH to 518b7db. Through specificity check 2, I 
showed that 518b7db were specific for LH because unlabeled 
LH competed with 1251-LH for binding to 518b7db, whereas 
unlabeled FSH did not compete with 125r-LH for binding to 
518b7db. From these specificity checks, I concluded that 
518b7db were specific for LH and therefore were suitable 
for use in the separation experiments. In addition, I ran 
a time course study to determine how long the anti-LH 
antibody used in these studies would remain attached to 
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the magnetic beads. 
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From this study, I determined that 
the anti-lJi antibody would remain attached to the magnetic 
beads for a period of at least 5 weeks. Therefore, I 
determined that I could use 518b7db for a period of at 
least 5 weeks because anti-lJi antibody did not dissociate 
from the magnetic beads during this time period. 
The second step of this thesis project was to use 
518b7db to perform experiment 1. During experiment 1, the 
negative separation procedure was used and inc-only and 
nonsep cells served as controls for this procedure. The 
1Ji data from experiment 1 suggests that I have shown that, 
with the use of 518b7db, it is possible to obtain an 
enriched 
uitary 
Cells 
fraction of viable lJi-secreting anterior pit-
cells from a mixed pituitary cell population. 
that were attached to the 518b7db secreted and 
contained more 1Ji than unbound, inc-only, nonsep, and 
control cells. 
The increased amount of 1Ji contained and secreted by 
cells bound to 518b7db is due to specificity of the 
separation procedure and not due to experimental artifacts 
because inc-only and nonsep cells did not differ from 
control cells. For example, the inc-only cells served as 
a control for the long incubation period used during the 
separation procedure. Since the amount of 1Ji secreted by 
and contained in these cells was not significantly 
different from control cells, I have shown that pituitary 
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cells remain viable during the incubation procedure and 
that incubation did not cause a change in the measured 
amount of LH secreted by or contained in a pituitary cell. 
The non-sep cells served as a control for the 
presence of 518b7db in the separation procedure. Since 
the amount of LH secreted by and contained in these cells 
did not differ from control cells, I have shown that the 
presence of 518b7db did not cause a change in the measured 
amount of LH secreted by or contained in a pituitary cell. 
In addition to measuring LH secretion and content in 
experiment 1, I also measured FSH secretion and content. 
The FSH data obtained show that the amount of FSH secreted 
by b518b7 cells is greater than the amount of FSH secreted 
by control, unbound, 
data suggest that 
inc-only, and nonsep cells. These 
cells bound to 518b7db secrete an 
increased amount of FSH as well as an increased amount of 
LH compared to all other magnetic bead treatment groups. 
When I compared the ratios of LH to FSH in the various 
magnetic bead treatment groups, I found that the ratios of 
LH to FSH did not differ between the cells bound to 
518b7db and control cells. This indicates that I have 
only separated cells that secrete both LH and FSH from the 
mixed cell population and that I did not separate any 
cells that secrete only LH because the ratio of LH to FSH 
was not increased in cells bound to 518b7db compared to 
control. These data were not unexpected because there is 
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evidence from immunocytochemistry that most gonadotropes 
secrete both LH and FSH and only a small population of 
gonadotropes secrete only LH or FSH.6, 7 Thus, it would be 
very difficult to remove the few cells that secrete only 
LH from a mixed cell population unless anti-FSH dynabeads 
were available. 
The LH data from experiment 2 also show that the 
amount of LH contained and secreted by b518b7 cells was 
increased compared to the u518b7, bNMS, uNMS, and control 
groups. These data again suggest that I have obtained an 
enriched fraction of LH-cells. 
I am certain that the increased LH secretion and 
content in b518b7 cells during experiment 2 was due to the 
specificity of the 518b7db binding to LH-secreting cells 
because NMSdb served as a control for nonspecific binding. 
NMSdb nonspecifically bind to LH-secreting cells as well 
as all other cell types present because cells do not 
contain a specific receptor for NMS. The nonspecificity 
of NMSdb was shown in specificity checks 1 and 2 through 
the dose-inhibition and dose-response curves. The binding 
of 125!-LH to NMSdb did not increase as the concentration 
of NMSdb increased and 125r-LH and nonradiolabeled LH did 
not compete for binding to NMSdb. Therefore, since the 
amount of LH secreted and contained by cells nonspecific-
ally bound to NMSdb was less than the amount of LH 
secreted and contained by b518b7 cells, I have shown the 
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separation procedure specifically removes LH-cells. 
During experiment 2, I also measured the amounts of 
FSH, TSH, and PRL secreted and contained by the different 
treatment groups. B518b7 cells contained and secreted an 
increased amount of FSH as compared to u518b7, bNMS, uNMS, 
and control cells. These data again suggest that I have 
removed pituitary cells that contain and secrete both FSH 
as well as LH. When I compared the ratio of LH to FSH in 
the different magnetic bead treatment groups, I found that 
there was no difference between the ratios of LH to FSH in 
cells bound to 518b7db and control cells. Again, this 
suggests that I have only removed cells that secrete and 
contain LH and FSH. These data support my hypothesis as 
well as the aforementioned results obtained with immuno-
cytochemistry. 6, 7 
The PRL and TSH data obtained from experiment 2 show 
that there are no significant differences between the 
amounts of PRL or TSH secreted by or contained in the 
b518b7, u518b7, bNMS, uNMS, and control cells. These data 
were expected because there is no evidence in the litera-
ture that supports the hypothesis that LH gonadotropes 
also contain and secrete PRL or TSH. I did not reduce the 
amount of PRL or TSH secreted by or contained in b518b7 
cells as compared to controls because I used a negative 
selection separation procedure so that I could obtain a 
large population of LH-secreting cells. During negative 
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selection, a large number of magnetic beads per cell is 
used to remove most cells secreting LH from a mixed 
anterior pituitary population. It is also possible that, 
because of the large number of magnetic beads used, some 
non-LH-secreting cells are also removed from the mixed 
population. In the future, it is possible to perform 
positive selection experiments which use a fewer number 
of magnetic beads per cell during the separation proced-
ure. This use of fewer beads would insure the removal of 
only a few pure gonadotropes from a mixed cell population 
and avoid the removal of non-LH-secreting cells. 
During experiment 2, I also treated some cells from 
each treatment group with GnRH, TRH, GHRH, CRH, or no 
releasing factor. This procedure was performed to show 
that the b518b7 cells were gonadotropes. For example, 
b518b7 cells should respond only to GnRH by increasing LH 
and FSH secretion and not to any other releasing factors 
because there is no evidence in the literature that TRH, 
GHRH, or CRH affect LH and FSH cell content and secretion. 
In addition, control cells and unbound cells should 
respond to TRH, CRH, and GHRH because they contain TSH-, 
PRL-, ACTH-, and GH-cells.41,42,43 The results that I 
obtained were unexpected and inconsistent. For example, I 
observed that in some cases CRH, TRH, and GHRH caused 
stimulation of LH and FSH. I also observed in some cases 
that GnRH affects PRL and TSH release and content. These 
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results suggest that further studies need to be done to 
determine exactly what effects various releasing factors 
have on Lli, FSH, TSH, and PRL secretion and content. It 
is possible, however, that these inconsistent and un-
expected data are due to cross-contamination of the 
releasing factors used during experiment 2. 
All of the aforementioned data show that I have de-
veloped a new method which can be 
enriched fraction of Lli gonadotropes. 
used to obtain an 
The use of this 
method enabled me to obtain a 3-fold purification of Lli-
cells. Although it is possible to obtain a 6 to 8-fold 
purification of Lli-cells with the use of a flourescence-
acti vated cell-sorter, centrifugal elutriation, and 
velocity sedimentation at unit gravity, this method can 
still be more useful than other techniques. This method 
is better than older techniques such as velocity sedimen-
tation at unit gravity, centrifugal elutriation, fluores-
cence-activated cell-sorting, and forward angle and 
perpendicular light scatter because it is far cheaper 
since it does not require a fluorescence-activated cell-
sorter, it allows a large number of cells to be separated 
at once, and virtually 100% of these cells remain viable. 
This separation technique can also be used in place of the 
reverse hemolytic plaque assay which does not prove useful 
for the study of FSH since it is difficult to obtain anti-
FSH antibodies suitable for use with immunocytochemical 
techniques. 
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Instead, this technique makes it possible to 
use anti-FSH antibody coated magnetic beads to obtain a 
pure population of FSH gonadotropes. In the future, it 
will also be possible to use this method to remove any 
cell type from a mixed cell population provided an 
antibody to the particular cell type is available. 
CONCWSIONS 
1. I have developed a fast, 
method to selectively remove 
reliable, and inexpensive 
gonadotropes that contain 
both LH and FSH from a mixed rat anterior pituitary cell 
population. 
2. I have used this method to support the hypothesis that 
most of the LH that is secreted from the anterior pit-
uitary is secreted from cells that contain both LH and 
FSH. 
3. This new method can be used to remove any cell type 
from a mixed cell population provided an antibody to the 
particular cell type is available. 
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